NIMG-67. ADVANCED PERFUSION AND DIFFUSION MR IMAGING IN GLIOBLASTOMA PATIENTS TREATED WITH TUMOR TREATING FIELDS (TTFIELDS) AS FIRST-LINE THERAPY

BACKGROUND: Tumor treating fields (TTFields) is an antimitotic and FDA-approved first and second-line therapy for patients with glioblastoma. In recurrent glioblastoma, it has been reported that imaging response to TTFields is generally delayed (~158 days), where 44% of responders developed initial...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Neuro Oncol
Hlavní autoři: Connelly, Jennifer M, Prah, Melissa A, Schmainda, Kathleen M
Médium: Artigo
Jazyk:Inglês
Vydáno: Oxford University Press 2017
Témata:
Abstracts
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC5692961/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/nox168.640
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky